BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27826762)

  • 21. Cartilage Defect Treatment Using High-Density Autologous Chondrocyte Implantation: Two-Year Follow-up.
    Lopez-Alcorocho JM; Aboli L; Guillen-Vicente I; Rodriguez-Iñigo E; Guillen-Vicente M; Fernández-Jaén TF; Arauz S; Abelow S; Guillen-García P
    Cartilage; 2018 Oct; 9(4):363-369. PubMed ID: 29156973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third generation autologous chondrocyte implantation is a good treatment option for athletic persons.
    Niethammer TR; Altmann D; Holzgruber M; Goller S; Fischer A; Müller PE
    Knee Surg Sports Traumatol Arthrosc; 2021 Apr; 29(4):1215-1223. PubMed ID: 32671436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial.
    Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B
    Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years.
    Niemeyer P; Laute V; Zinser W; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Fickert S
    Knee Surg Sports Traumatol Arthrosc; 2020 Apr; 28(4):1130-1143. PubMed ID: 31897548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Effectiveness of Cartilage Repair With Respect to the Minimal Clinically Important Difference.
    Jones KJ; Kelley BV; Arshi A; McAllister DR; Fabricant PD
    Am J Sports Med; 2019 Nov; 47(13):3284-3293. PubMed ID: 31082325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study.
    Akgun I; Unlu MC; Erdal OA; Ogut T; Erturk M; Ovali E; Kantarci F; Caliskan G; Akgun Y
    Arch Orthop Trauma Surg; 2015 Feb; 135(2):251-263. PubMed ID: 25548122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous chondrocyte implantation: Is it likely to become a saviour of large-sized and full-thickness cartilage defect in young adult knee?
    Zhang C; Cai YZ; Lin XJ
    Knee Surg Sports Traumatol Arthrosc; 2016 May; 24(5):1643-50. PubMed ID: 25986097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.
    Crawford DC; DeBerardino TM; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Return to Sports Activity and Work After Autologous Chondrocyte Implantation of the Knee: Which Factors Influence Outcomes?
    Pestka JM; Feucht MJ; Porichis S; Bode G; Südkamp NP; Niemeyer P
    Am J Sports Med; 2016 Feb; 44(2):370-7. PubMed ID: 26657264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Chondrocytic Gene Expression Is Associated With Improved Repair Tissue Quality and Graft Survival in Patients After Autologous Chondrocyte Implantation.
    Ackermann J; Merkely G; Mestriner AB; Shah N; Gomoll AH
    Am J Sports Med; 2019 Oct; 47(12):2919-2926. PubMed ID: 31433670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Outcomes of Autologous Chondrocyte Implantation in Adolescent Patients.
    Ogura T; Bryant T; Minas T
    Am J Sports Med; 2017 Apr; 45(5):1066-1074. PubMed ID: 28129512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation: a review of 28 cases].
    Robert H; Bahuaud J; Kerdiles N; Passuti N; Capelli M; Pujol JP; Hartman D; Locker B; Hulet C; Hardy P; Coudane H; Rochverger A; Francheschi JP;
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):701-9. PubMed ID: 18065881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft Hypertrophy After Third-Generation Autologous Chondrocyte Implantation Has No Correlation With Reduced Cartilage Quality: Matched-Pair Analysis Using T2-Weighted Mapping.
    Niethammer TR; Loitzsch A; Horng A; Baur-Melnyk A; Bendiks M; Gülecyüz MF; Müller PE; Pietschmann MF
    Am J Sports Med; 2018 Aug; 46(10):2414-2421. PubMed ID: 30063401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-generation versus second-generation autologous chondrocyte implantation for treatment of cartilage defects of the knee: a matched-pair analysis on long-term clinical outcome.
    Niemeyer P; Salzmann G; Feucht M; Pestka J; Porichis S; Ogon P; Südkamp N; Schmal H
    Int Orthop; 2014 Oct; 38(10):2065-70. PubMed ID: 24838370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arthroscopic gel-type autologous chondrocyte implantation presents histologic evidence of regenerating hyaline-like cartilage in the knee with articular cartilage defect.
    Yoon TH; Jung M; Choi CH; Kim HS; Lee YH; Choi YS; Kim SJ; Kim SH
    Knee Surg Sports Traumatol Arthrosc; 2020 Mar; 28(3):941-951. PubMed ID: 31240378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogel-based autologous chondrocyte implantation leads to subjective improvement levels comparable to scaffold based autologous chondrocyte implantation.
    Niethammer TR; Uhlemann F; Zhang A; Holzgruber M; Wagner F; Müller PE
    Knee Surg Sports Traumatol Arthrosc; 2022 Oct; 30(10):3386-3392. PubMed ID: 35226109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee: A Randomized Clinical Trial.
    Niemeyer P; Laute V; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Niks M; Fickert S; Zinser W
    Am J Sports Med; 2016 Aug; 44(8):2005-14. PubMed ID: 27206690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes after cell-seeded autologous chondrocyte implantation of the knee: when can success or failure be predicted?
    Pestka JM; Bode G; Salzmann G; Steinwachs M; Schmal H; Südkamp NP; Niemeyer P
    Am J Sports Med; 2014 Jan; 42(1):208-15. PubMed ID: 24166804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation: results at 5 years' follow-up.
    Gobbi A; Kon E; Berruto M; Filardo G; Delcogliano M; Boldrini L; Bathan L; Marcacci M
    Am J Sports Med; 2009 Jun; 37(6):1083-92. PubMed ID: 19465733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is implantation of autologous chondrocytes superior to microfracture for articular-cartilage defects of the knee? A systematic review of 5-year follow-up data.
    Na Y; Shi Y; Liu W; Jia Y; Kong L; Zhang T; Han C; Ren Y
    Int J Surg; 2019 Aug; 68():56-62. PubMed ID: 31220632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.